FIA
QNTM

FNY Investment Advisers’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

FNY Investment Advisers’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-108
Closed -$10K – 1058
2020
Q4 		$10K Buy
+108
New +$12.7K ﹤0.01% 591

Other funds holding QNTM

IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
RPC
Rossmore Private Capital Glastonbury, Connecticut $1.24B AUM 28.92% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

FNY Investment Advisers's QNTM Position: Q1 2021 in Review

FNY Investment Advisers sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2021, closing a stake of 108 shares — an estimated $10K sold.

FNY Investment Advisers first reported a position in QNTM in Q4 2020 and held it in 1 quarter. The position peaked at $10K in Q4 2020. 19 funds tracked by Wall St. Rank hold QNTM as of Q1 2021.

  • FNY Investment Advisers reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2021 after selling out during the quarter.
  • FNY Investment Advisers sold 108 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2021, an estimated $10K.
  • FNY Investment Advisers first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2020 and held it in 1 quarter.
  • FNY Investment Advisers's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $10K in Q4 2020.
  • 19 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2021.

Based on FNY Investment Advisers's 13F filing for Q1 2021, filed 12 Apr 2021.